CSIMarket
 


Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Cumulative Purple Biotech Ltd 's Quick Ratio for Trailing Twelve Months Period

PPBT's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PPBT Quick Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Growth 66.07 % 66.07 % 66.07 % 66.07 % 37.19 %
Y / Y Cash & cash equivalent Growth 38.02 % 38.02 % 38.02 % 38.02 % -3.17 %
Quick Ratio for Trailing Twelve Months Period 2.13 2.2 2.29 2.41 2.56
Total Ranking # 1310 # 1302 # 1494 # 1537 # 1464
Seq. Current Liabilities Growth 0 % 0 % 0 % 66.07 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % 38.02 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV. Quarter to $7 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 2.13 below Purple Biotech Ltd average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 386 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Purple Biotech Ltd . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about PPBT
Quick Ratio PPBT in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 387
Sector # 683
S&P 500 # 1286


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.63 2.26 1.24
(Dec 31 2020)   (Dec 31 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Trevi Therapeutics Inc   5.83 
Cue Biopharma Inc   5.82 
Maravai Lifesciences Holdings Inc   5.82 
Vanda Pharmaceuticals Inc   5.80 
Arbutus Biopharma Corp  5.79 
Nuvectis Pharma inc   5.76 
Guardion Health Sciences Inc   5.69 
Bellicum Pharmaceuticals Inc   5.64 
Schrodinger Inc   5.50 
Trevena inc   5.50 
Landos Biopharma Inc   5.47 
Tricida Inc   5.46 
China Health Industries Holdings Inc   5.45 
Apellis Pharmaceuticals Inc   5.42 
Lexicon Pharmaceuticals Inc   5.42 
Arcus Biosciences Inc   5.41 
Siga Technologies Inc  5.36 
Syros Pharmaceuticals Inc   5.36 
I mab  5.31 
Igc Pharma Inc   5.30 
Oncolytics Biotech Inc   5.25 
Arvinas Inc   5.20 
Regulus Therapeutics Inc   5.15 
Cellectar Biosciences Inc   5.14 
Plx Pharma Inc   5.14 
Corvus Pharmaceuticals Inc   5.13 
Verastem Inc   5.13 
Imunon Inc   5.12 
Merus N v   5.10 
Unity Biotechnology Inc   5.09 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com